ITEMS IN AFP WITH KEYWORD:
Labor, Delivery, Postpartum
Sep 1, 2020 Issue
Placental Alpha Macroglobulin-1 (PartoSure) Immunoassay to Assess the Risk of Spontaneous Preterm Birth [Diagnostic Tests: What Physicians Need to Know]
Placental alpha macroglobulin-1 (PartoSure-TM) immunoassay to assess the risk of spontaneous preterm birth.
Aug 1, 2020 Issue
Fetal Fibronectin Testing in Threatened Preterm Labor [Medicine by the Numbers]
Continuous electronic fetal monitoring was developed to screen for signs of hypoxic-ischemic encephalopathy, cerebral palsy, and impending fetal death during labor; it is appropriately used in high-risk labor. Structured intermittent auscultation can be used in low-risk labor and can lower operative vaginal and cesarean deliveries; however, structured intermittent auscultation remains difficult to implement because of perceived barriers in nurse staffing and physician oversight.
Shoulder dystocia is an obstetric emergency. It can lead to neonatal brachial plexus injuries, hypoxia, and maternal trauma. Most cases occur without warning, but prior shoulder dystocia and preexisting or gestational diabetes mellitus increase risk. Each institution should consider the length of time it will take to prepare the operating room for general inhalational anesthesia and abdominal rescue and practice this during simulation exercises.
Jun 1, 2020 Issue
Potential of Fetal Fibronectin Testing to Prevent Preterm Birth [Cochrane for Clinicians]
Fetal fibronectin testing may reduce preterm birth, although the evidence is not strong enough to recommend regular testing.
Postpartum hemorrhage is the most common cause of maternal death worldwide. Tranexamic acid is an antifibrinolytic agent that has shown to decrease bleeding in surgical patients and all-cause death in trauma patients. Does early administration of tranexamic acid reduce the rate of death and hysterec...
Family physicians can catalyze efforts to ensure the safety of all people who give birth and to support well-being during the postpartum period.
Health issues in the postpartum period may include medical complications, patient concerns, and conditions that may cause future health risks. Treating these issues during the postpartum period is important to the new mother’s immediate and long-term health. Postpartum care should be initiated within three weeks after delivery, and a full assessment should be performed within 12 weeks.
Sep 1, 2019 Issue
Treatment of Threatened Miscarriage with Progestogens [Cochrane for Clinicians]
Progestogens reduce the risk of miscarriage when compared with placebo in patients with threatened miscarriage (number needed to treat [NNT] = 10.) Use of progestogens poses no significant risks to mother or baby.
Aug 15, 2019 Issue
Asthma, Back and Neck Pain, Pain During Labor, TIA, CBT for Anxiety [AFP Clinical Answers]
Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.